5 min listen
Valeant's dose of reality
FromFT News in Focus
ratings:
Length:
9 minutes
Released:
Dec 2, 2015
Format:
Podcast episode
Description
Valeant was once considered a runaway success story, and one that upended the pharmaceutical sector. A series of crises engulfed the company in recent months, slashing nearly two thirds off its market valuation and forcing the company to tear up its forecasts for 2016. Correspondent David Crow explains. Read the full story at ft.com/valeant.
Music: "Brand New Record!" by Steve Combs For information regarding your data privacy, visit acast.com/privacy
Music: "Brand New Record!" by Steve Combs For information regarding your data privacy, visit acast.com/privacy
Released:
Dec 2, 2015
Format:
Podcast episode
Titles in the series (100)
Call between Danielle Chiesi and Kieran Taylor on October 10, 2008 by FT News in Focus